Skistosomiasis

01Pathophysiology

Schistosomiasis is a parasitic disease caused by blood flukes that inhabit the venous plexuses of the host. The life cycle begins when cercariae (the infective larval form) are released from freshwater snails and penetrate intact human skin during contact with contaminated freshwater. This penetration can cause an immediate pruritic papular rash known as cercarial dermatitis (swimmer's itch), which represents a local hypersensitivity response at the entry site.

Once inside the host, the cercariae transform into schistosomula, which enter the venous circulation and migrate through the lungs and eventually reach the portal venous system. Over several weeks, they mature into adult worm pairs. The adult worms of S. mansoni and S. japonicum reside in the mesenteric venous plexus (inferior and superior, respectively), while S. haematobium adults migrate to the vesical venous plexus surrounding the bladder.

The critical concept to understand is that the eggs, not the adult worms, are responsible for virtually all of the tissue damage. Each female worm produces hundreds to thousands of eggs daily. Some eggs penetrate through the vessel wall and the intestinal or bladder mucosa to be excreted in stool or urine, completing the life cycle. However, a significant proportion of eggs fail to reach the lumen and instead become trapped in the tissues (intestinal wall, liver, bladder wall, and occasionally ectopic sites).

These trapped eggs provoke a vigorous CD4+ T-helper type 2 (Th2) granulomatous immune response. The host immune system walls off each egg with a granuloma composed of eosinophils, macrophages, and fibroblasts. This is why eosinophilia is a hallmark laboratory finding. Over time, chronic granulomatous inflammation leads to progressive fibrosis.

In hepatosplenic disease (S. mansoni and S. japonicum), eggs carried by portal blood are filtered out in the liver, where they lodge in the periportal spaces. The resulting granulomas and fibrosis produce the characteristic Symmers periportal (pipestem) fibrosis. This fibrosis is periportal, not parenchymal, meaning it causes presinusoidal portal hypertension while the hepatocytes themselves remain healthy. This is the reason why patients develop esophageal varices, splenomegaly, and ascites but maintain normal synthetic liver function (normal albumin, normal coagulation). This distinction from cirrhosis is heavily tested.

In urogenital disease (S. haematobium), eggs trapped in the bladder wall cause chronic granulomatous inflammation, fibrosis, and calcification. The sustained inflammatory stimulus drives squamous metaplasia of the urothelium, which over years can progress to squamous cell carcinoma (SCC) of the bladder. This is a classic association: in endemic regions, S. haematobium is the leading cause of bladder cancer, and notably it causes SCC rather than the transitional cell (urothelial) carcinoma that predominates in non-endemic settings.

Ectopic egg deposition can occur in the lungs (leading to pulmonary hypertension from granulomatous obliteration of pulmonary arterioles) and the central nervous system. S. japonicum has a predilection for the brain (cerebral schistosomiasis with seizures), while S. mansoni and S. haematobium more commonly affect the spinal cord (transverse myelitis).

02Classification and Clinical Manifestation

A note on S. japonicum: this species produces far more eggs per day than the other two species, which accounts for the generally more severe intestinal and hepatosplenic disease, and its higher propensity for cerebral involvement.

03Diagnostic Workup

The diagnostic approach to schistosomiasis depends heavily on the clinical phase and the patient's epidemiologic background.

For a patient with chronic symptoms and residence in an endemic area, the best initial test is direct microscopic identification of eggs in stool (for S. mansoni and S. japonicum) or in urine (for S. haematobium). Egg morphology is the single most important feature for species identification. The lateral spine of S. mansoni, the terminal spine of S. haematobium, and the small round shape of S. japonicum eggs are classic exam images. For urine collection, midday specimens (10 AM to 2 PM) after light exercise maximize egg yield because of the diurnal excretion pattern. Multiple samples on different days improve sensitivity, as egg shedding is intermittent.

In the acute phase (Katayama fever), egg excretion may not yet have started because the worms have not fully matured. In this scenario, and in travelers with low-intensity infections, serology becomes the most helpful screening tool. A positive antibody test in a traveler with fever, eosinophilia, and recent freshwater exposure in an endemic area is highly suggestive of acute schistosomiasis. However, serology has limitations: it cannot differentiate between active and past infection and is not useful in endemic populations due to widespread prior exposure.

The most accurate (gold standard) test is tissue biopsy demonstrating granulomas with identifiable eggs. Rectal snip biopsy is the classic confirmatory test for intestinal schistosomiasis, and cystoscopy with bladder biopsy confirms urogenital disease. In practice, biopsy is reserved for cases where noninvasive testing is negative but clinical suspicion remains high.

Abdominal ultrasound is essential in evaluating for hepatosplenic involvement. The hallmark finding is periportal fibrosis with characteristic echogenic cuffing around portal vein branches, the sonographic correlate of Symmers pipestem fibrosis. This pattern, combined with findings of portal hypertension (dilated portal vein, splenomegaly, collateral vessels) and normal hepatic parenchyma, is virtually diagnostic.

A key point: always check liver function tests in any patient with suspected hepatosplenic schistosomiasis. The finding of portal hypertension with preserved synthetic function (normal albumin, normal PT/INR, normal or mildly elevated transaminases) points toward presinusoidal obstruction (schistosomiasis) rather than cirrhosis.

04Management and Treatment

Praziquantel is the cornerstone of treatment for all forms of schistosomiasis. It works by increasing the permeability of the tegument of adult worms to calcium, causing muscular contraction, paralysis, and tegumental damage, which exposes worm surface antigens to the host immune system. The immune system then destroys the paralyzed worms.

The dosing difference between species is commonly tested. S. japonicum requires a higher total dose (60 mg/kg in 3 divided doses) because of the heavier egg burden and the greater tissue involvement associated with this species. S. mansoni and S. haematobium are treated with 40 mg/kg in 2 divided doses. All doses are given on a single day.

A critical management principle involves the sequencing of therapy in Katayama fever. In the acute phase, the immune system is already in a state of intense hypersensitivity to worm and egg antigens. If praziquantel is given during this phase, the sudden release of additional antigens from dying worms can paradoxically worsen the inflammatory response, potentially causing a clinical deterioration similar to a Jarisch-Herxheimer reaction. Therefore, the correct sequence is: administer corticosteroids first to suppress the immune reaction, then give praziquantel once the acute symptoms have resolved. A repeat course of praziquantel 4 to 6 weeks later is recommended because the drug is effective only against adult worms, not the immature schistosomula that may have been present during initial treatment.

For neuroschistosomiasis, corticosteroids are given simultaneously with praziquantel to prevent or mitigate the inflammatory surge that follows egg and worm death within the confined space of the central nervous system.

Praziquantel is generally well tolerated. Side effects (headache, dizziness, abdominal discomfort, nausea) are usually mild and transient. It is considered safe in pregnancy in endemic settings where the benefit of treatment outweighs risk, though some guidelines recommend deferring treatment to the second or third trimester when possible.

Regarding long-term management of hepatosplenic complications: praziquantel kills the worms and halts new egg production, but established periportal fibrosis is irreversible. Patients with esophageal varices require standard portal hypertension surveillance and management, including endoscopic screening, band ligation for active bleeding, and beta-blocker prophylaxis.

For urogenital disease, treatment with praziquantel can reverse early bladder lesions, but advanced fibrosis, calcification, and malignant transformation are not reversible. Patients with long-standing S. haematobium infection and chronic hematuria should be evaluated for squamous cell carcinoma of the bladder with cystoscopy and biopsy.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students lose points on schistosomiasis questions is by confusing it with cirrhosis. When a vignette describes a patient with esophageal varices, ascites, and splenomegaly, many examinees reflexively select cirrhosis without checking the liver function panel. The vignette will deliberately include normal albumin, normal INR, and absent stigmata of chronic liver disease (no palmar erythema, no spider angiomata, no gynecomastia). This is the signal that the portal hypertension is presinusoidal, pointing you toward schistosomiasis rather than cirrhosis. Always look for the travel or exposure history embedded somewhere in the stem.

A second major trap involves the type of bladder cancer caused by S. haematobium. The expected answer is squamous cell carcinoma, not transitional cell (urothelial) carcinoma. This catches students who correctly identify schistosomiasis but then select the wrong malignancy type. Remember the mechanism: chronic granulomatous inflammation drives squamous metaplasia, which can progress to squamous cell carcinoma.

Third, the sequencing of treatment in Katayama fever is frequently tested. The instinct to give praziquantel immediately is wrong. The correct first step is corticosteroids, with praziquantel deferred until the acute inflammatory phase resolves. Giving praziquantel during active Katayama fever can worsen the immune-mediated reaction.

Fourth, egg morphology is a classic image-based question. You must be able to distinguish the lateral spine (S. mansoni), the terminal spine (S. haematobium), and the small round egg with a rudimentary knob (S. japonicum). If the vignette mentions eggs found in urine, it is S. haematobium regardless of the image.

Finally, remember the ectopic patterns: S. japonicum goes to the brain (seizures), while S. mansoni and S. haematobium go to the spinal cord (transverse myelitis). This is tested as a neurologic emergency in a patient with recent travel to an endemic area.

The core competency being tested with schistosomiasis questions is the ability to integrate epidemiologic exposure (freshwater contact in an endemic region), recognize the hallmark of preserved hepatic function despite portal hypertension, correctly identify the causative species based on egg morphology and organ involvement, and apply the correct sequencing of treatment, particularly in the acute phase.